Determination of metabolites of a novel platinum anticancer drug JM216 in human plasma ultrafiltrates
- 30 November 1995
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 13 (12) , 1493-1498
- https://doi.org/10.1016/0731-7085(95)01571-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- New platinum antitumor complexesPublished by Elsevier ,1993
- Electrospray ionization mass spectrometry for analysis of low-molecular-weight anticancer drugs and their analoguesJournal of the American Society for Mass Spectrometry, 1993
- Ammine/amine platinum (IV) dicarboxylates: A lead to the discovery of a new generation of broad spectrum platinum-based anticancer drugsDrugs of the Future, 1993
- Electrospray ionization mass spectrometry of platinum anticancer agentsJournal of Mass Spectrometry, 1991
- Analytical methodologies for the quantitation of platinum anti-cancer drugs and related compounds in biological mediaJournal of Pharmaceutical and Biomedical Analysis, 1990
- Chemotherapeutic agent Cisplatin monitoring in biological fluids by means of inductively-coupled plasma emission spectrometry (ICP-AES)Clinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- Preclinical studies identifying carboplatin as a viable cisplatin alternativeCancer Treatment Reviews, 1985
- Charles F. Kettring prize. Fundamental studies with cisplatinCancer, 1985
- A method for determining cis-dichlorodiammineplatinum(II) in plasma and urine by high performance liquid chromatography with direct ultraviolet detection.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatinBiochemical Pharmacology, 1984